(Q30375250)

19 August 2017

Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice. (English)

1 reference

19 August 2017

0 references

25

J Craig Venter

0 references

George F. Gao

18

object named as

George F Gao

1 reference

19 August 2017

27

Rino Rappuoli

1 reference

19 August 2017

26

Philip R Dormitzer

1 reference

19 August 2017

17

Bolyn Hubby

1 reference

19 August 2017

Armin Hekele

1

1 reference

19 August 2017

Sylvie Bertholet

2

1 reference

19 August 2017

Jacob Archer

3

1 reference

19 August 2017

Daniel G Gibson

4

1 reference

19 August 2017

Giuseppe Palladino

5

1 reference

19 August 2017

Luis A Brito

6

1 reference

19 August 2017

Gillis R Otten

7

1 reference

19 August 2017

Michela Brazzoli

8

1 reference

19 August 2017

Scilla Buccato

9

1 reference

19 August 2017

Alessandra Bonci

10

1 reference

19 August 2017

Daniele Casini

11

1 reference

19 August 2017

Domenico Maione

12

1 reference

19 August 2017

Zhi-Qing Qi

13

1 reference

19 August 2017

John E Gill

14

1 reference

19 August 2017

Nicky C Caiazza

15

1 reference

19 August 2017

Jun Urano

16

1 reference

19 August 2017

Yuelong Shu

19

1 reference

19 August 2017

Ennio De Gregorio

20

1 reference

19 August 2017

Christian W Mandl

21

1 reference

19 August 2017

Peter W Mason

22

1 reference

19 August 2017

Ethan C Settembre

23

1 reference

19 August 2017

Jeffrey B Ulmer

24

1 reference

19 August 2017

Andrew J Geall

28

1 reference

19 August 2017

14 August 2013

1 reference

Emerging Microbes & Infections

19 August 2017

1 reference

19 August 2017

2

1 reference

19 August 2017

8

1 reference

19 August 2017

e52

1 reference

RNA: the new revolution in nucleic acid vaccines

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Synthetic generation of influenza vaccine viruses for rapid response to pandemics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Human infection with a novel avian-origin influenza A (H7N9) virus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Real-time numerical forecast of global epidemic spreading: case study of 2009 A/H1N1pdm.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Nonviral delivery of self-amplifying RNA vaccines

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Influenza: options to improve pandemic preparation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

New technologies for influenza vaccines

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

The first influenza pandemic of the new millennium

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

DNA vaccine manufacture: scale and quality

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Vaccines: correlates of vaccine-induced immunity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Nucleic acid isothermal amplification technologies: a review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Long-term storage of DNA-free RNA for use in vaccine studies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Vaccination with messenger RNA (mRNA).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Haemagglutination-inhibiting antibody to influenza virus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Inactivated influenza vaccines. 2. Laboratory indices of protection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3821287

Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FEMI.2013.54

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FEMI.2013.54

Messenger RNA-based vaccines

21 January 2018

1 reference

12 December 2020

New influenza A (H1N1) virus: global epidemiological situation, June 2009

1 reference

12 December 2020

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

1 reference

12 December 2020

An alternative renewable source of squalene for use in emulsion adjuvants

1 reference

12 December 2020

Identifiers

DOI

10.1038/EMI.2013.54

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

26038486

1 reference